Is the US prepared to deal with another pandemic or widespread health crisis?

Short answer: More prepared than in 2019, but still not ready enough for a fast‑moving, nationwide health emergency.

What’s better now

•Faster detection and data: CDC has a published, measurable 2024–2025 Public Health Data Strategy and continues multi‑year “data modernization” to speed reporting from clinics and labs and link state/local systems. Wastewater surveillance, built during COVID‑19, now tracks multiple pathogens (e.g., SARS‑CoV‑2, influenza A/H5, RSV, mpox) and has scaled nationally, improving early warning.[1]

•Clearer federal coordination points: HHS’s Administration for Strategic Preparedness and Response (ASPR) was elevated to an operating division (2022), and the White House created the Office of Pandemic Preparedness and Response Policy (OPPR) to coordinate across departments and drive medical‑countermeasure development. The 2022 National Biodefense Strategy lays out a whole‑of‑government plan.[2]

•Medical countermeasures and manufacturing: BARDA has sustained programs for rapid vaccine and therapeutic development and invested in domestic surge manufacturing and fill/finish capacity, especially for influenza and emerging infectious diseases.[3]

What still puts the U.S. at risk

•Strategic gaps flagged by federal watchdogs: GAO still lists “HHS leadership and coordination of public health emergencies” on the 2025 High‑Risk List, and as of mid‑2025 it reported the U.S. lacked a fully coordinated national diagnostic‑testing strategy for pandemic threats (HHS said a framework was in development). These are core issues for early response.[4]

•Workforce fragility: State and local health departments report high vacancy rates and burnout; the local workforce bump during COVID was temporary and uneven, which threatens surge capacity and sustained operations.[5]

•Uneven state readiness and funding: Independent scorecards find wide state‑to‑state variation in laboratory surge planning, public health funding trends, hospital safety, and access to paid sick leave—factors that determine how fast communities can act. 2025–2026 editions of “Ready or Not” warn that preparedness remains inconsistent.[6]

•Stockpile and supply chain: The Strategic National Stockpile (SNS) has been modernizing after documented COVID‑era shortfalls, but ensuring right‑sized, non‑expiring inventories and resilient domestic supply chains is an ongoing task.[7]

•Surveillance blind spots: Wastewater and other systems don’t have uniform coverage; CDC notes some states still have “limited/no data” in recent weeks, which can delay local signal detection.[8]

Bottom line

•The U.S. can see threats sooner, move data faster, and develop countermeasures more quickly than before COVID‑19—a meaningful step forward. But persistent leadership/coordination gaps, workforce strain, uneven state capacity, and supply‑chain fragility mean a severe, fast‑spreading pandemic could still outpace parts of the system—especially if public trust and uptake of guidance are low.[4]

What to watch or strengthen next

•Lock in stable, multi‑year preparedness funding and finish modernizing data/reporting across states (so early signals aren’t missed).[1]

•Publish and regularly update a national diagnostic‑testing framework with clear roles, pre‑approved assays, and data standards.[9]

•Rebuild and protect the public‑health workforce (hiring flexibility, competitive pay, mental‑health supports, training pipelines).[5]

•Sustain wastewater and genomic surveillance coverage nationwide and integrate with clinical/hospital data for rapid situational awareness.[10]

•Continue SNS and domestic manufacturing modernization tied to realistic demand forecasting and expiry management.[11]

If helpful, I can tailor this down to your state or metro area—funding trends, lab capacity, wastewater coverage, and hospital surge indicators—so you can see what readiness looks like where you live.

Citations (11)

1cdc.govGovernment
CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health Threats | CDC Online Newsroom | CDC
Backs: “Wastewater surveillance, built during COVID‑19, now tracks multiple pathogens (e.g., SARS‑CoV‑2, influenza A/H5, RSV, mpox) and has scaled nationally, improving early warning.”
2aspr.govGovernment
About ASPR | ASPR
Backs: “The 2022 National Biodefense Strategy lays out a whole‑of‑government plan.”
3medicalcountermeasures.govGovernment
Medical Countermeasures | Influenza & Emerging Infectious Diseases (IED) Pandemic Vaccines & Adjuvants Program
Backs: “BARDA has sustained programs for rapid vaccine and therapeutic development and invested in domestic surge manufacturing and fill/finish capacity, especially for influenza and emerging infectious diseases.”
4gao.govGovernment
GAO-25-107743, HIGH-RISK SERIES: Heightened Attention to High-Risk Areas Could Yield Billions in Savings and A More Efficient and Effective Government
Backs: “GAO still lists “HHS leadership and coordination of public health emergencies” on the 2025 High‑Risk List, and as of mid‑2025 it reported the U.S. lacked a fully coordinated national diagnostic‑testing strategy for pandemic threats (HHS said a framework was in development). These are core issues for early response.”
5gao.govGovernment
GAO-25-107002, PUBLIC HEALTH PREPAREDNESS: HHS and Jurisdictions Have Taken Some Steps to Address Challenging Workforce Gaps
Backs: “State and local health departments report high vacancy rates and burnout; the local workforce bump during COVID was temporary and uneven, which threatens surge capacity and sustained operations.”
6tfah.orgNonprofits and think tanks
Ready or Not 2025: Protecting the Public’s Health from Diseases, Disasters, and Bioterrorism - TFAH
Backs: “2025–2026 editions of “Ready or Not” warn that preparedness remains inconsistent.”
7hhs.govGovernment
The Strategic National Stockpile Was Not Positioned To Respond Effectively to the COVID-19 Pandemic | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services
Backs: “The Strategic National Stockpile (SNS) has been modernizing after documented COVID‑era shortfalls, but ensuring right‑sized, non‑expiring inventories and resilient domestic supply chains is an ongoing task.”
8cdc.govGovernment
COVID-19 Wastewater Data – National Trends | NWSS | CDC
Backs: “CDC notes some states still have “limited/no data” in recent weeks, which can delay local signal detection.”
9gao.govGovernment
Public Health Preparedness: HHS Needs a Coordinated National Approach for Diagnostic Testing for Pandemic Threats | U.S. GAO
Backs: “Publish and regularly update a national diagnostic‑testing framework with clear roles, pre‑approved assays, and data standards.”
10cdc.govGovernment
Progress and Expansion of the National Wastewater Surveillance System, United States, 2020–2024 - Volume 32, Supplement—August 2026 - Emerging Infectious Diseases journal - CDC
Backs: “Sustain wastewater and genomic surveillance coverage nationwide and integrate with clinical/hospital data for rapid situational awareness.”
11hhs.govGovernment
HHS ASPR Justification of Estimates for Appropriations Committee for Fiscal Year 2025
Backs: “Continue SNS and domestic manufacturing modernization tied to realistic demand forecasting and expiry management.”